Patents by Inventor Laure Jamot

Laure Jamot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition including the HIP/PAP protein or one of the derivatives thereof for treating insulin resistance
    Patent number: 9629896
    Abstract: The invention relates to a HIP/PAP protein or to one of the derivatives thereof for use thereof for treating or preventing insulin resistance in non-insulin dependent subjects.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: April 25, 2017
    Assignees: ALFACT INNOVATION, INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS SUD, UNIVERSITE PARIS DIDEROT—PARIS 7
    Inventors: Fabrizio Andreelli, Paul Amouyal, Christophe Magnan, Celine Cruciani-Guglielmacci, Jamila Vaivre, Marion Darnaud, Laure Jamot, Christian Brechot, Gilles Amouyal
  • HIP/PAP protein and derivatives thereof for use in treating cancer
    Patent number: 9474783
    Abstract: This invention concerns a HIP/PAP protein or derivative thereof, for its use in treating or managing cancer and preferentially solid tumors.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: October 25, 2016
    Assignees: ALFACT INNOVATION, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS SUD
    Inventors: Jamila Faivre, Eric Vibert, Marion Darnaud, Laure Jamot, Christian Brechot, Paul Amouyal, Gilles Amouyal
  • Composition Including the HIP/PAP Protein or One of the Derivatives Thereof for Treating Insulin Resistance
    Publication number: 20160058833
    Abstract: The invention relates to a HIP/PAP protein or to one of the derivatives thereof for use thereof for treating or preventing insulin resistance in non-insulin dependent subjects.
    Type: Application
    Filed: April 4, 2014
    Publication date: March 3, 2016
    Inventors: Fabrizio Andreelli, Paul Amouyal, Christophe Magnan, Celine Cruciani-Guglielmacci, Jamila Vaivre, Marion Darnaud, Laure Jamot, Christian Brechot, Gilles Amouyal
  • HIP/PAP PROTEIN AND DERIVATIVES THEREOF FOR USE IN TREATING CANCER
    Publication number: 20150190465
    Abstract: This invention concerns a HIP/PAP protein or derivative thereof, for its use in treating or managing cancer and preferentially solid tumors.
    Type: Application
    Filed: July 18, 2013
    Publication date: July 9, 2015
    Inventors: Jamila Faivre, Eric Vibert, Marion Darnaud, Laure Jamot, Christian Brechot, Paul Amouyal, Gilles Amouyal
  • Chemical compounds and the uses thereof as a medicine
    Patent number: 8691854
    Abstract: The present invention relates to the field of pharmacy, especially the treatment of neurodegenerative diseases. The invention specifically relates to a family of chemical compounds for which a neuroprotective activity has been demonstrated. Given that certain members of said family are novel compounds which have never been described, the invention relates to said novel products, the synthesis method thereof and certain novel intermediate synthesis products. The present invention further relates to compositions comprising the compounds of said family, and the use of said compounds as medicaments, especially for the preparation of a medicament for the treatment of neurodegenerative diseases.
    Type: Grant
    Filed: June 29, 2006
    Date of Patent: April 8, 2014
    Assignee: Trophos
    Inventors: Corinne Chaimbault, Cyrille Drouot, Laure Jamot, Rebecca Pruss, Céline Simon
  • NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE
    Publication number: 20090203747
    Abstract: The present invention relates to the field of pharmacy, especially the treatment of neurodegenerative diseases. The invention specifically relates to a family of chemical compounds for which a neuroprotective activity has been demonstrated. Given that certain members of said family are novel compounds which have never been described, the invention relates to said novel products, the synthesis method thereof and certain novel intermediate synthesis products. The present invention further relates to compositions comprising the compounds of said family, and the use of said compounds as medicaments, especially for the preparation of a medicament for the treatment of neurodegenerative diseases.
    Type: Application
    Filed: June 29, 2006
    Publication date: August 13, 2009
    Applicant: Trophos Parc Scientifique Luminy
    Inventors: Corinne Chaimbault, Cyrille Drouot, Laure Jamot, Rebecca Pruss, Celine Simon